Carbamoylcholine Completed Phase 3 Trials for Presbyopia Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05270863Safety and Efficacy Study BRIMOCHOLâ„¢ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic Presbyopia